
The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
K. John Morrow, Jr., PhD, is president of Newport Biotechnology Consultants, 625 Washington Avenue, Newport, KY 41071, kjohnmorrowjr@insightbb.com.
The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
Innovative products and a range of indications drive the therapeutic antibody market.
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.
Two films portray, in surprising detail, the hard work and determination of the biopharmaceutical industry.
These are dismal times for anyone wishing to start a biotech company. The US economy and stock market are in the tank, and venture capital is tight. At least 100 of the publicly traded biotechs this year will fail or be taken over. So why would a entrepreneur want to further disadvantage himself by locating his company miles away from traditional biotech hubs like San Diego, Boston, and Rockville?
Nupotential, a small Louisiana biotechnology firm, believes it may have an answer to the ethical concerns and technological challenges involved in turning stem cells into medical therapies.
Nupotential, a small Louisiana biotechnology firm, believes it may have an answer to the ethical concerns and technological challenges involved in turning stem cells into medical therapies.
In one series of experiments, the glycosylation site of IgG1 was removed and an IgA glycosylation site was introduced-resulting in a total loss of biological function.
Although difficult to conceive, the 21st century may see the boundaries of biological knowledge completely defined.
Virtually every corner of the United States (not to mention the rest of the world) seeks to build a powerful biotech presence (see www.bio.org/local/). Since the dawn of biotechnology in the mid 1970s, private venture capital, major corporations, and state and federal governments have poured hundreds of billions of dollars into the industry. Results have been mixed, in terms of benefits to local economies and products that reached the marketplace.
Cities, counties, states; every political entity in our country is driving to develop a biotechnology presence in its respective region.
An old saying goes, "Success has a thousand fathers; failure is an orphan."
The nanotechnology vision of tiny microrobots that could move inside the body carrying out complex surgical repairs has been touted incessantly until it has become a clich?.
A powerful film will have a hundred times the impact of a touchy-feely commercial.
At this time there are no effective diagnostic tests for cancer that are rapid, economical, highly specific, and highly sensitive. This deficiency means that many cases of malignancy go undetected until long past the time of effective treatment. Much cancer research, including investigations carried out by both the academic and private sector, is focused on combining therapy and diagnostics as "theragnostics."
In March of 1932, socialite and millionaire playboy Eben M. Byers died of a horrible and mysterious disease, his body corroded until his bones began to shatter apart. Strikingly handsome in his youth, by the time of his death a series of last ditch operations had eliminated the lower part of his face and reduced him to a distorted shadow of his former self. His bizarre death was the result of his addiction to a quack cure, radium-laced water.
Published: January 1st 2013 | Updated:
Published: October 1st 2013 | Updated:
Published: February 1st 2013 | Updated:
Published: May 1st 2011 | Updated:
Published: July 10th 2009 | Updated:
Published: June 12th 2009 | Updated: